To me, as a company in the bio space, I think this is a substantial blog entry. Thanks for posting the link. This is a great view into the strategy of one of their three current solutions, repurposing Metformin, one of the most widely prescribed drugs in the world and currently being used to treat diabetes, into an eye drop med to help treat eye degeneration disease in the elderly, a massive market opportunity.
As an investor, not a trader, the words I liked reading the most were the final ones...”Wet AMD to Stargardt’s is a perfect example and also a good example of when starting big is the right decision.” We should all like “big” when it comes to a solution. If they are successful in developing this solution the sky is the limit.